packageMasitinib

masitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Masitinib is a protein kinase inhibitor investigated as a cancer treatment, including for pancreatic cancer, gastrointestinal stromal tumours, mastocytosis and amyotrophic lateral sclerosis. It is not approved for human use in the European Union, where marketing applications have been refused, but it is an approved veterinary medicine and remains investigational in humans.

Summary written by glm-5.3-flash from Wikidata Q1907109 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:masitinib
ATC codes:L01EX06, L01XE, L01XE22
DrugBank:DB11526
PubChem CID:10074640
ChEBI:63450
Wikidata:Q1907109
formula:C28H30N6OS
molar mass:498.649 g/mol (PubChem CID 10074640)
logP:4.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown